| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | STARD13 GAPVD1 TBC1D15 IQSEC2 RASGEF1A ARHGAP17 PREX2 ARAP3 SIPA1L1 KNDC1 AKAP13 HERC2 ARHGEF2 SOS2 | 1.31e-04 | 507 | 172 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | STARD13 GAPVD1 TBC1D15 IQSEC2 RASGEF1A ARHGAP17 PREX2 ARAP3 SIPA1L1 KNDC1 AKAP13 HERC2 ARHGEF2 SOS2 | 1.31e-04 | 507 | 172 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 1.58e-04 | 32 | 172 | 4 | GO:0005452 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | GAPVD1 IQSEC2 RASGEF1A PREX2 KNDC1 AKAP13 HERC2 ARHGEF2 SOS2 | 1.82e-04 | 231 | 172 | 9 | GO:0005085 |
| GeneOntologyBiologicalProcess | heart development | IFT140 FAT4 FN1 PKD1L1 LRRC10 APC MYLK2 AXIN2 LEFTY2 TBX18 LEFTY1 BMPR2 NPHP3 MTHFD1 VCAN DCHS1 AKAP13 NOS3 NOTCH2 PCNT DNAH11 | 1.44e-06 | 757 | 172 | 21 | GO:0007507 |
| GeneOntologyBiologicalProcess | axis specification | 4.83e-06 | 113 | 172 | 8 | GO:0009798 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 5.63e-06 | 5 | 172 | 3 | GO:0045053 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | IFT140 TBC1D15 VPS13C TOM1 APC CUL9 ARHGAP17 PIWIL2 NUF2 CUL7 AXIN2 DDX11 PIKFYVE LMOD3 GDA VPS13D CELSR1 MAPK15 SIPA1L1 SVIL PAN2 AKAP13 ARHGEF2 ARMH3 CX3CL1 CDH5 CNOT1 SMG6 | 6.29e-06 | 1342 | 172 | 28 | GO:0033043 |
| GeneOntologyBiologicalProcess | heart morphogenesis | FAT4 APC MYLK2 AXIN2 LEFTY2 LEFTY1 BMPR2 NPHP3 DCHS1 NOS3 NOTCH2 DNAH11 | 1.69e-05 | 321 | 172 | 12 | GO:0003007 |
| GeneOntologyBiologicalProcess | circulatory system development | STARD13 IFT140 FAT4 FN1 PKD1L1 LRRC10 APC CUL7 ITGA5 MYLK2 AXIN2 LEFTY2 TBX18 LEFTY1 BMPR2 NPHP3 NFATC2 MTHFD1 VCAN DCHS1 AKAP13 CX3CL1 CDH5 EIF2AK3 NOS3 NOTCH2 PCNT DNAH11 | 2.36e-05 | 1442 | 172 | 28 | GO:0072359 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.82e-05 | 187 | 172 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | pattern specification process | IFT140 PKD1L1 APC DSCAML1 AXIN2 LEFTY2 TBX18 LEFTY1 BMPR2 CELSR1 NPHP3 PCSK6 DCHS1 NOTCH2 DNAH11 | 3.64e-05 | 526 | 172 | 15 | GO:0007389 |
| GeneOntologyBiologicalProcess | determination of left/right symmetry | 4.61e-05 | 154 | 172 | 8 | GO:0007368 | |
| GeneOntologyBiologicalProcess | heart valve development | 4.82e-05 | 78 | 172 | 6 | GO:0003170 | |
| GeneOntologyBiologicalProcess | regionalization | IFT140 PKD1L1 APC DSCAML1 AXIN2 LEFTY2 TBX18 LEFTY1 BMPR2 CELSR1 NPHP3 PCSK6 NOTCH2 DNAH11 | 5.01e-05 | 478 | 172 | 14 | GO:0003002 |
| GeneOntologyBiologicalProcess | left/right pattern formation | 6.60e-05 | 162 | 172 | 8 | GO:0060972 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 FAT3 ITGA5 DSCAML1 CELSR1 HMCN2 PTPRF DCHS1 NECTIN4 CX3CL1 CDH5 | 6.66e-05 | 313 | 172 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | nodal receptor complex assembly | 6.91e-05 | 2 | 172 | 2 | GO:0038099 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal receptor complex assembly | 6.91e-05 | 2 | 172 | 2 | GO:1900124 | |
| GeneOntologyBiologicalProcess | regulation of nodal receptor complex assembly | 6.91e-05 | 2 | 172 | 2 | GO:1900123 | |
| GeneOntologyBiologicalProcess | determination of bilateral symmetry | 7.51e-05 | 165 | 172 | 8 | GO:0009855 | |
| GeneOntologyBiologicalProcess | specification of symmetry | 7.51e-05 | 165 | 172 | 8 | GO:0009799 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 1.04e-04 | 173 | 172 | 8 | GO:0031333 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.81e-04 | 63 | 172 | 5 | GO:0003179 | |
| GeneOntologyBiologicalProcess | mitral valve morphogenesis | 2.41e-04 | 15 | 172 | 3 | GO:0003183 | |
| GeneOntologyBiologicalProcess | mitral valve development | 2.95e-04 | 16 | 172 | 3 | GO:0003174 | |
| MousePheno | abnormal somite development | IFT140 SUPT20H FN1 ITGA5 F5 DDX11 LEFTY2 TBX18 LEFTY1 MTHFD1 VCAN CDH5 | 2.71e-06 | 222 | 142 | 12 | MP:0001688 |
| MousePheno | abnormal left-right axis patterning | 5.03e-06 | 67 | 142 | 7 | MP:0001706 | |
| MousePheno | impaired somite development | 1.05e-05 | 104 | 142 | 8 | MP:0009768 | |
| MousePheno | abnormal interatrial septum morphology | 1.30e-05 | 107 | 142 | 8 | MP:0000282 | |
| MousePheno | left pulmonary isomerism | 1.38e-05 | 31 | 142 | 5 | MP:0003178 | |
| MousePheno | abnormal cardiovascular development | STARD13 IFT140 SUPT20H FN1 APC CHD4 CUL7 ITGA5 AXIN2 DDX11 LEFTY2 TBX18 LEFTY1 BMPR2 ARAP3 VCAN PCSK6 AKAP13 MED23 CDH5 NOS3 PCNT | 1.88e-05 | 802 | 142 | 22 | MP:0002925 |
| MousePheno | left-sided isomerism | 2.21e-05 | 34 | 142 | 5 | MP:0000542 | |
| MousePheno | abnormal lung position or orientation | 2.34e-05 | 57 | 142 | 6 | MP:0010853 | |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 2.56e-05 | 35 | 142 | 5 | MP:0004522 | |
| MousePheno | abnormal placenta development | 3.67e-05 | 160 | 142 | 9 | MP:0001712 | |
| MousePheno | left atrial isomerism | 5.54e-05 | 8 | 142 | 3 | MP:0008461 | |
| MousePheno | prenatal growth retardation | IFT140 GAPVD1 SUPT20H FN1 PKD1L1 CUL7 ITGA5 PIR TRIP12 KIAA0753 DDX11 BMPR2 MTHFD1 VCAN DDX18 AKAP13 MED23 CDH5 NOS3 NOTCH2 PCNT SMG6 | 6.33e-05 | 869 | 142 | 22 | MP:0010865 |
| MousePheno | absent somites | 6.34e-05 | 42 | 142 | 5 | MP:0006386 | |
| MousePheno | abnormal cardiac outflow tract development | 6.61e-05 | 134 | 142 | 8 | MP:0006126 | |
| MousePheno | embryonic lethality during organogenesis | IFT140 FN1 PITRM1 APC BBS1 ITGA5 TRIP12 F5 AXIN2 DDX11 LEFTY2 DAP3 LEFTY1 BMPR2 ARAP3 MTHFD1 VCAN AKAP13 MED23 ARMH3 CDH5 NOTCH2 | 7.13e-05 | 876 | 142 | 22 | MP:0006207 |
| MousePheno | accessory spleen | 8.24e-05 | 9 | 142 | 3 | MP:0003342 | |
| MousePheno | decreased kidney cell proliferation | 8.24e-05 | 9 | 142 | 3 | MP:0011441 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | IFT140 FN1 PITRM1 APC ITGA5 TRIP12 DDX11 LEFTY2 DAP3 LEFTY1 BMPR2 ARAP3 MTHFD1 VCAN AKAP13 MED23 ARMH3 CDH5 NOTCH2 | 8.51e-05 | 700 | 142 | 19 | MP:0011098 |
| MousePheno | abnormal lung morphology | IFT140 NEU4 FAT4 POLE PKD1L1 CUL9 LYST PIKFYVE LEFTY2 LEFTY1 BMPR2 CELSR1 GYG1 PCSK6 DCHS1 SIGLEC1 NOS3 PCNT DNAH11 SLC23A3 | 9.47e-05 | 767 | 142 | 20 | MP:0001175 |
| MousePheno | abnormal embryo development | GAPVD1 SUPT20H FN1 PKD1L1 APC ITGA5 PIR TRIP12 AXIN2 KIAA0753 DDX11 PIKFYVE LEFTY2 DAP3 LEFTY1 BMPR2 NPHP3 ARAP3 MTHFD1 VCAN PCSK6 DDX18 AKAP13 MED23 CDH5 NOTCH2 PCNT SMG6 DNAH11 | 1.00e-04 | 1370 | 142 | 29 | MP:0001672 |
| MousePheno | abnormal left renal vein morphology | 1.02e-04 | 2 | 142 | 2 | MP:0011327 | |
| MousePheno | abnormal renal vein morphology | 1.02e-04 | 2 | 142 | 2 | MP:0011323 | |
| MousePheno | abnormal right lung morphology | 1.10e-04 | 47 | 142 | 5 | MP:0009570 | |
| MousePheno | abnormal heart atrium morphology | FAT4 PIKFYVE LEFTY2 LEFTY1 VCAN PCSK6 DCHS1 NOS3 PCNT DNAH11 | 1.28e-04 | 232 | 142 | 10 | MP:0003105 |
| MousePheno | failure of somite differentiation | 1.48e-04 | 50 | 142 | 5 | MP:0001690 | |
| MousePheno | dextrocardia | 1.63e-04 | 51 | 142 | 5 | MP:0000644 | |
| MousePheno | abnormal extraembryonic tissue physiology | SUPT20H FN1 CHD4 CUL7 ITGA5 TRIP12 PGR DDX11 LEFTY2 DAP3 LEFTY1 ARAP3 | 2.07e-04 | 345 | 142 | 12 | MP:0004264 |
| MousePheno | atrioventricular septal defect | 2.10e-04 | 84 | 142 | 6 | MP:0010412 | |
| MousePheno | abnormal embryonic growth/weight/body size | GAPVD1 SUPT20H FN1 PKD1L1 APC CUL7 ITGA5 PIR TRIP12 AXIN2 KIAA0753 DDX11 PIKFYVE DAP3 BMPR2 PIEZO2 ARAP3 PNPLA1 MTHFD1 VCAN DDX18 AKAP13 MED23 CDH5 NOTCH2 PCNT SMG6 | 2.33e-04 | 1295 | 142 | 27 | MP:0002088 |
| MousePheno | abnormal placenta physiology | 2.36e-04 | 204 | 142 | 9 | MP:0010038 | |
| MousePheno | abnormal embryo turning | 2.43e-04 | 251 | 142 | 10 | MP:0001700 | |
| MousePheno | abnormal atrioventricular septum morphology | 2.54e-04 | 87 | 142 | 6 | MP:0010592 | |
| MousePheno | embryonic growth retardation | GAPVD1 SUPT20H FN1 PKD1L1 ITGA5 PIR TRIP12 KIAA0753 DDX11 BMPR2 MTHFD1 VCAN DDX18 AKAP13 MED23 CDH5 NOTCH2 PCNT SMG6 | 2.59e-04 | 763 | 142 | 19 | MP:0003984 |
| MousePheno | atrial septal defect | 2.70e-04 | 88 | 142 | 6 | MP:0010403 | |
| MousePheno | curly tail | 2.76e-04 | 57 | 142 | 5 | MP:0003051 | |
| MousePheno | abnormal kidney venous blood vessel morphology | 3.05e-04 | 3 | 142 | 2 | MP:0011311 | |
| MousePheno | heterotaxia | 3.05e-04 | 90 | 142 | 6 | MP:0004133 | |
| MousePheno | abnormal extraembryonic tissue morphology | SUPT20H FN1 PITRM1 BBS1 CUL7 ITGA5 TRIP12 F5 DDX11 PIKFYVE LEFTY2 DAP3 LEFTY1 BMPR2 CELSR1 ARAP3 VCAN MED23 ARMH3 CDH5 NOTCH2 | 3.29e-04 | 908 | 142 | 21 | MP:0002086 |
| MousePheno | abnormal embryonic tissue morphology | IFT140 FAT4 SUPT20H FN1 APC ITGA5 F5 AXIN2 DDX11 LEFTY2 TBX18 LEFTY1 BMPR2 CELSR1 MTHFD1 VCAN PCSK6 DDX18 DCHS1 AKAP13 MED23 CDH5 PCNT DNAH11 | 3.49e-04 | 1116 | 142 | 24 | MP:0002085 |
| MousePheno | abnormal vascular development | STARD13 SUPT20H FN1 CUL7 ITGA5 LEFTY2 TBX18 LEFTY1 BMPR2 ARAP3 VCAN MED23 CDH5 NOS3 PCNT | 4.06e-04 | 542 | 142 | 15 | MP:0000259 |
| MousePheno | abnormal prenatal growth/weight/body size | IFT140 GAPVD1 SUPT20H FN1 PKD1L1 APC CUL7 ITGA5 PIR TRIP12 AXIN2 KIAA0753 DDX11 PIKFYVE DAP3 BMPR2 PIEZO2 ARAP3 PNPLA1 MTHFD1 VCAN DDX18 AKAP13 MED23 CDH5 NOS3 NOTCH2 PCNT SMG6 | 4.37e-04 | 1493 | 142 | 29 | MP:0004196 |
| MousePheno | abnormal hepatic portal vein morphology | 5.22e-04 | 16 | 142 | 3 | MP:0010668 | |
| MousePheno | failure of chorioallantoic fusion | 5.87e-04 | 67 | 142 | 5 | MP:0009657 | |
| MousePheno | absent vitelline blood vessels | 5.87e-04 | 67 | 142 | 5 | MP:0001719 | |
| MousePheno | abnormal heart septum morphology | IFT140 FAT4 CHD4 LEFTY2 LEFTY1 BMPR2 VCAN PCSK6 DCHS1 NOS3 PCNT DNAH11 | 5.98e-04 | 388 | 142 | 12 | MP:0006113 |
| MousePheno | abnormal cardiac jelly morphology | 6.07e-04 | 4 | 142 | 2 | MP:0009382 | |
| MousePheno | abnormal large intestine placement | 6.07e-04 | 4 | 142 | 2 | MP:0003284 | |
| MousePheno | abnormal heart atrium arrangement | 6.29e-04 | 17 | 142 | 3 | MP:0014319 | |
| MousePheno | abnormal vitelline vasculature morphology | 6.62e-04 | 235 | 142 | 9 | MP:0003229 | |
| MousePheno | abnormal atrioventricular valve morphology | 6.72e-04 | 69 | 142 | 5 | MP:0002745 | |
| MousePheno | abnormal developmental patterning | SUPT20H FN1 PKD1L1 APC ITGA5 KIAA0753 LEFTY2 DAP3 LEFTY1 BMPR2 NPHP3 VCAN PCSK6 CDH5 DNAH11 | 7.75e-04 | 577 | 142 | 15 | MP:0002084 |
| MousePheno | absent notochord | 8.83e-04 | 19 | 142 | 3 | MP:0000932 | |
| MousePheno | abnormal placenta morphology | FN1 PITRM1 BBS1 CUL7 TRIP12 DDX11 DAP3 CELSR1 ARAP3 VCAN MED23 ARMH3 CDH5 NOTCH2 | 9.13e-04 | 525 | 142 | 14 | MP:0001711 |
| MousePheno | abnormal heart position or orientation | 9.25e-04 | 74 | 142 | 5 | MP:0006065 | |
| MousePheno | embryonic lethality, incomplete penetrance | FN1 APC BBS1 F5 AXIN2 PIKFYVE LEFTY2 LEFTY1 BMPR2 VCAN CDH5 SMG6 | 9.68e-04 | 410 | 142 | 12 | MP:0011102 |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | FN1 APC BBS1 F5 AXIN2 PIKFYVE LEFTY2 LEFTY1 BMPR2 VCAN CDH5 SMG6 | 9.68e-04 | 410 | 142 | 12 | MP:0031660 |
| MousePheno | abnormal gastrulation | SUPT20H FN1 PKD1L1 APC ITGA5 KIAA0753 LEFTY2 DAP3 LEFTY1 BMPR2 NPHP3 VCAN CDH5 | 9.83e-04 | 469 | 142 | 13 | MP:0001695 |
| MousePheno | abnormal heart atrium and ventricle connection | 9.83e-04 | 75 | 142 | 5 | MP:0010435 | |
| MousePheno | abnormal pulmonary vascular resistance | 1.00e-03 | 5 | 142 | 2 | MP:0003033 | |
| MousePheno | enlarged endometrial glands | 1.00e-03 | 5 | 142 | 2 | MP:0009251 | |
| MousePheno | wide sternum | 1.00e-03 | 5 | 142 | 2 | MP:0012279 | |
| MousePheno | incomplete somite formation | 1.01e-03 | 44 | 142 | 4 | MP:0001689 | |
| MousePheno | abnormal primary cilium morphology | 1.07e-03 | 114 | 142 | 6 | MP:0013203 | |
| Domain | Cul7 | 7.15e-07 | 3 | 168 | 3 | PF11515 | |
| Domain | CPH_domain | 7.15e-07 | 3 | 168 | 3 | IPR021097 | |
| Domain | Rib_L2_dom2 | 1.75e-05 | 18 | 168 | 4 | IPR014722 | |
| Domain | - | 1.75e-05 | 18 | 168 | 4 | 2.30.30.30 | |
| Domain | APC_su10/DOC_dom | 2.44e-05 | 7 | 168 | 3 | IPR004939 | |
| Domain | DOC | 2.44e-05 | 7 | 168 | 3 | PS51284 | |
| Domain | ANAPC10 | 2.44e-05 | 7 | 168 | 3 | PF03256 | |
| Domain | APC10 | 2.44e-05 | 7 | 168 | 3 | SM01337 | |
| Domain | ASX_HYDROXYL | 3.33e-05 | 100 | 168 | 7 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.85e-05 | 106 | 168 | 7 | IPR000152 | |
| Domain | - | 5.01e-05 | 73 | 168 | 6 | 2.60.120.260 | |
| Domain | LRDF | 8.04e-05 | 2 | 168 | 2 | IPR003942 | |
| Domain | EGF-like_dom | 8.82e-05 | 249 | 168 | 10 | IPR000742 | |
| Domain | EGF_CA | 1.18e-04 | 122 | 168 | 7 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.31e-04 | 124 | 168 | 7 | IPR001881 | |
| Domain | Galactose-bd-like | 2.05e-04 | 94 | 168 | 6 | IPR008979 | |
| Domain | VPS13 | 2.40e-04 | 3 | 168 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 2.40e-04 | 3 | 168 | 2 | PF16910 | |
| Domain | VPS13 | 2.40e-04 | 3 | 168 | 2 | PF16908 | |
| Domain | VPS13_N2 | 2.40e-04 | 3 | 168 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 2.40e-04 | 3 | 168 | 2 | IPR031642 | |
| Domain | EGF_Ca-bd_CS | 2.44e-04 | 97 | 168 | 6 | IPR018097 | |
| Domain | EGF_CA | 2.72e-04 | 99 | 168 | 6 | PS01187 | |
| Domain | EGF | 2.84e-04 | 235 | 168 | 9 | SM00181 | |
| Domain | EGF_3 | 2.84e-04 | 235 | 168 | 9 | PS50026 | |
| Domain | SHR-BD | 4.77e-04 | 4 | 168 | 2 | IPR009543 | |
| Domain | VPS13_C | 4.77e-04 | 4 | 168 | 2 | PF16909 | |
| Domain | VPS13_C | 4.77e-04 | 4 | 168 | 2 | IPR031645 | |
| Domain | SHR-BD | 4.77e-04 | 4 | 168 | 2 | PF06650 | |
| Domain | EGF_1 | 5.14e-04 | 255 | 168 | 9 | PS00022 | |
| Domain | EGF-like_CS | 6.08e-04 | 261 | 168 | 9 | IPR013032 | |
| Domain | Cadherin-like | 6.36e-04 | 116 | 168 | 6 | IPR015919 | |
| Domain | EGF_2 | 6.77e-04 | 265 | 168 | 9 | PS01186 | |
| Domain | RasGEFN | 7.28e-04 | 20 | 168 | 3 | SM00229 | |
| Domain | - | 8.33e-04 | 47 | 168 | 4 | 3.30.420.10 | |
| Domain | RasGEF_N | 8.44e-04 | 21 | 168 | 3 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 9.71e-04 | 22 | 168 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 9.71e-04 | 22 | 168 | 3 | PS50212 | |
| Domain | RASGEF | 1.60e-03 | 26 | 168 | 3 | PS00720 | |
| Domain | Ig-like_fold | SIGLEC12 FN1 SGCA IL22RA1 DSCAML1 HMCN2 PTPRF NFATC2 SIGLEC6 VCAN NECTIN4 ASTN1 SIGLEC1 EPB42 SORL1 | 1.81e-03 | 706 | 168 | 15 | IPR013783 |
| Domain | Chorein_N | 2.17e-03 | 8 | 168 | 2 | PF12624 | |
| Domain | Cullin_neddylation_domain | 2.17e-03 | 8 | 168 | 2 | IPR019559 | |
| Domain | Cullin_Nedd8 | 2.17e-03 | 8 | 168 | 2 | PF10557 | |
| Domain | VPS13_N | 2.17e-03 | 8 | 168 | 2 | IPR026854 | |
| Domain | Cullin_Nedd8 | 2.17e-03 | 8 | 168 | 2 | SM00884 | |
| Domain | RASGEF_CAT | 2.20e-03 | 29 | 168 | 3 | PS50009 | |
| Domain | RasGEF | 2.43e-03 | 30 | 168 | 3 | PF00617 | |
| Domain | - | 2.43e-03 | 30 | 168 | 3 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 2.43e-03 | 30 | 168 | 3 | IPR001895 | |
| Domain | RasGEF | 2.43e-03 | 30 | 168 | 3 | SM00147 | |
| Domain | Ras_GEF_dom | 2.43e-03 | 30 | 168 | 3 | IPR023578 | |
| Domain | DH_1 | 2.49e-03 | 63 | 168 | 4 | PS00741 | |
| Domain | - | SIGLEC12 FN1 SGCA IL22RA1 DSCAML1 PTPRF NFATC2 SIGLEC6 VCAN NECTIN4 ASTN1 SIGLEC1 EPB42 SORL1 | 2.71e-03 | 663 | 168 | 14 | 2.60.40.10 |
| Domain | Cullin_homology | 2.78e-03 | 9 | 168 | 2 | IPR016158 | |
| Domain | Sialidases | 2.78e-03 | 9 | 168 | 2 | IPR011040 | |
| Domain | TGF-beta-rel | 2.93e-03 | 32 | 168 | 3 | IPR015615 | |
| Domain | TGFb_CS | 2.93e-03 | 32 | 168 | 3 | IPR017948 | |
| Domain | Cadherin_CS | 3.05e-03 | 109 | 168 | 5 | IPR020894 | |
| Domain | RhoGEF | 3.29e-03 | 68 | 168 | 4 | SM00325 | |
| Domain | Cullin | 3.45e-03 | 10 | 168 | 2 | PF00888 | |
| Domain | PTrfase/Anion_transptr | 3.45e-03 | 10 | 168 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 3.45e-03 | 10 | 168 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 3.45e-03 | 10 | 168 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 3.45e-03 | 10 | 168 | 2 | IPR011531 | |
| Domain | CULLIN_2 | 3.45e-03 | 10 | 168 | 2 | PS50069 | |
| Domain | Cullin_N | 3.45e-03 | 10 | 168 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 3.45e-03 | 10 | 168 | 2 | PS01256 | |
| Domain | RNaseH-like_dom | 3.47e-03 | 69 | 168 | 4 | IPR012337 | |
| Domain | CADHERIN_1 | 3.57e-03 | 113 | 168 | 5 | PS00232 | |
| Domain | Cadherin | 3.57e-03 | 113 | 168 | 5 | PF00028 | |
| Domain | RhoGEF | 3.65e-03 | 70 | 168 | 4 | PF00621 | |
| Domain | DH_2 | 3.65e-03 | 70 | 168 | 4 | PS50010 | |
| Domain | CADHERIN_2 | 3.70e-03 | 114 | 168 | 5 | PS50268 | |
| Domain | - | 3.70e-03 | 114 | 168 | 5 | 2.60.40.60 | |
| Domain | - | 3.84e-03 | 71 | 168 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 3.84e-03 | 71 | 168 | 4 | IPR000219 | |
| Domain | CA | 3.84e-03 | 115 | 168 | 5 | SM00112 | |
| Domain | Cadherin | 4.29e-03 | 118 | 168 | 5 | IPR002126 | |
| Domain | TGF-b_C | 4.44e-03 | 37 | 168 | 3 | IPR001839 | |
| Domain | TGF_BETA_1 | 4.44e-03 | 37 | 168 | 3 | PS00250 | |
| Domain | TGFB | 4.44e-03 | 37 | 168 | 3 | SM00204 | |
| Domain | TGF_BETA_2 | 4.44e-03 | 37 | 168 | 3 | PS51362 | |
| Domain | TGF_beta | 4.44e-03 | 37 | 168 | 3 | PF00019 | |
| Domain | LAM_G_DOMAIN | 4.79e-03 | 38 | 168 | 3 | PS50025 | |
| Domain | GDS_CDC24_CS | 5.15e-03 | 39 | 168 | 3 | IPR001331 | |
| Domain | IGc2 | 5.46e-03 | 235 | 168 | 7 | SM00408 | |
| Domain | Ig_sub2 | 5.46e-03 | 235 | 168 | 7 | IPR003598 | |
| Domain | Laminin_G_2 | 5.53e-03 | 40 | 168 | 3 | PF02210 | |
| Domain | C2-set_2 | 5.93e-03 | 41 | 168 | 3 | PF08205 | |
| Domain | CD80_C2-set | 5.93e-03 | 41 | 168 | 3 | IPR013162 | |
| Domain | SAM_2 | 6.78e-03 | 43 | 168 | 3 | PF07647 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.82e-03 | 14 | 168 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 6.82e-03 | 14 | 168 | 2 | IPR024743 | |
| Domain | EXOIII | 6.82e-03 | 14 | 168 | 2 | SM00479 | |
| Domain | Exonuclease_RNaseT/DNA_pol3 | 6.82e-03 | 14 | 168 | 2 | IPR013520 | |
| Domain | RNase_T | 6.82e-03 | 14 | 168 | 2 | PF00929 | |
| Domain | MT | 6.82e-03 | 14 | 168 | 2 | PF12777 | |
| Domain | AAA_8 | 6.82e-03 | 14 | 168 | 2 | PF12780 | |
| Domain | LamG | 7.23e-03 | 44 | 168 | 3 | SM00282 | |
| Domain | Ig_I-set | 7.52e-03 | 190 | 168 | 6 | IPR013098 | |
| Pubmed | 3.67e-10 | 9 | 174 | 5 | 28705793 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GAPVD1 STIM2 HIPK4 IQSEC2 MINK1 APC ARHGAP17 TRIP12 LYST CARD8 MYLK2 KIAA0753 MLXIPL VPS13D BMPR2 SIPA1L1 SVIL AKAP13 ARHGEF2 NOTCH2 | 1.43e-08 | 861 | 174 | 20 | 36931259 |
| Pubmed | 2.09e-08 | 130 | 174 | 9 | 12421765 | ||
| Pubmed | 1.23e-07 | 3 | 174 | 3 | 17011489 | ||
| Pubmed | 1.94e-07 | 11 | 174 | 4 | 27272319 | ||
| Pubmed | 4.18e-07 | 13 | 174 | 4 | 17884984 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 9348041 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 9990851 | ||
| Pubmed | 4.91e-07 | 4 | 174 | 3 | 9708732 | ||
| Pubmed | Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. | 4.91e-07 | 4 | 174 | 3 | 8610011 | |
| Pubmed | Essential roles of fibronectin in the development of the left-right embryonic body plan. | 7.91e-07 | 15 | 174 | 4 | 21466802 | |
| Pubmed | AMBN IFT140 SUPT20H FAT3 CUL9 CHD4 CUL7 ACY1 DCAF5 DAP3 HMCN2 SIPA1L1 PCSK6 DDX18 SIGLEC1 ZNF281 NOTCH2 SLC4A11 SORL1 WDR72 | 9.04e-07 | 1116 | 174 | 20 | 31753913 | |
| Pubmed | 1.22e-06 | 5 | 174 | 3 | 10385627 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.34e-06 | 212 | 174 | 9 | 33853758 | |
| Pubmed | 1.37e-06 | 17 | 174 | 4 | 22357932 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | STRBP POLE FARSB CHD4 CUL7 OGDH TRIP12 NOP14 DDX18 KCTD20 BOP1 HERC2 ARHGEF2 MED23 ZC3H7B CNOT1 | 1.53e-06 | 759 | 174 | 16 | 35915203 |
| Pubmed | FAT4 GAPVD1 STIM2 FN1 VPS13C MINK1 APC MUC16 CHD4 TRIP12 DMXL1 EPS15L1 OSBPL2 MTHFD1 DDX18 NOTCH2 | 2.07e-06 | 777 | 174 | 16 | 35844135 | |
| Pubmed | GAPVD1 TBC1D15 SUPT20H IQSEC2 TOM1 APC ACAD10 DSCAML1 DCAF5 KIAA0753 DAP3 EPS15L1 SVIL AKAP13 DNAH11 | 2.23e-06 | 689 | 174 | 15 | 36543142 | |
| Pubmed | Genetic risk factors for placental abruption: a HuGE review and meta-analysis. | 2.43e-06 | 6 | 174 | 3 | 18277167 | |
| Pubmed | 2.43e-06 | 6 | 174 | 3 | 10678167 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | POLE CUL9 ARHGAP17 KTI12 ITGA5 LYST PIKFYVE EPS15L1 CELSR1 ARAP3 PTPRF AKAP13 HERC2 ARHGEF2 ZC3H7B NOTCH2 PCNT SMG6 RASD2 | 3.14e-06 | 1105 | 174 | 19 | 35748872 |
| Pubmed | Wnt3a links left-right determination with segmentation and anteroposterior axis elongation. | 3.39e-06 | 21 | 174 | 4 | 16291790 | |
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 9825674 | ||
| Pubmed | 4.24e-06 | 7 | 174 | 3 | 16059920 | ||
| Pubmed | 4.98e-06 | 23 | 174 | 4 | 14623818 | ||
| Pubmed | STRBP POLE KIAA0753 DDX11 PIKFYVE SIPA1L1 BOP1 ARHGEF2 CNOT1 | 5.34e-06 | 251 | 174 | 9 | 29778605 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | AMFR FN1 STRBP APC FARSB ACAD10 F5 PREX2 DMXL1 SIPA1L1 BOP1 HERC2 | 5.44e-06 | 475 | 174 | 12 | 31040226 |
| Pubmed | GAPVD1 FN1 STRBP POLE CUL9 CHD4 CUL7 TRIP12 NOP14 DDX18 BOP1 HERC2 CNOT1 PCNT | 5.86e-06 | 653 | 174 | 14 | 22586326 | |
| Pubmed | Rac1 mediates morphogenetic responses to intercellular signals in the gastrulating mouse embryo. | 5.95e-06 | 24 | 174 | 4 | 21693517 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TBC1D15 STIM2 PITRM1 VPS13C POLE NUF2 CUL7 OGDH MRPL35 PIKFYVE DAP3 VPS13D NOP14 DDX18 BOP1 HERC2 ARHGEF2 MRPL24 EIF2AK3 QRSL1 PCNT SMG6 | 6.24e-06 | 1496 | 174 | 22 | 32877691 |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 6.32e-06 | 90 | 174 | 6 | 35654790 | |
| Pubmed | Notch signaling regulates left-right asymmetry determination by inducing Nodal expression. | 6.77e-06 | 8 | 174 | 3 | 12730124 | |
| Pubmed | Two nodal-responsive enhancers control left-right asymmetric expression of Nodal. | 6.77e-06 | 8 | 174 | 3 | 15736223 | |
| Pubmed | 6.77e-06 | 8 | 174 | 3 | 21802298 | ||
| Pubmed | PIERCE1 is critical for specification of left-right asymmetry in mice. | 6.77e-06 | 8 | 174 | 3 | 27305836 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GAPVD1 STRBP POLE FARSB CUL9 CHD4 CUL7 TRIP12 NOP14 NFATC2 ARHGEF2 NHEJ1 MRPL24 EIF2AK3 NOTCH2 SORL1 | 7.15e-06 | 857 | 174 | 16 | 25609649 |
| Pubmed | SUPT20H FN1 IQSEC2 APC CUL9 CHD4 TRIP12 SLC4A3 OLR1 DSCAML1 DCAF5 EPS15L1 RPRD1A SIPA1L1 PCSK6 DDX18 ASTN1 HERC2 PCNT SOS2 | 7.50e-06 | 1285 | 174 | 20 | 35914814 | |
| Pubmed | TBC1D15 STIM2 VPS13C TOM1 ITGA5 LYST DMXL1 PIKFYVE VPS13D HEATR5B EIF2AK3 NOTCH2 | 9.86e-06 | 504 | 174 | 12 | 34432599 | |
| Pubmed | Pkd1l1 establishes left-right asymmetry and physically interacts with Pkd2. | 1.01e-05 | 9 | 174 | 3 | 21307093 | |
| Pubmed | SPC4/PACE4 regulates a TGFbeta signaling network during axis formation. | 1.44e-05 | 10 | 174 | 3 | 10809672 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GAPVD1 APC CHD4 TRIP12 RPRD1A DDX18 BOP1 HERC2 ARHGEF2 MED23 EIF2AK3 | 1.49e-05 | 440 | 174 | 11 | 34244565 |
| Pubmed | 1.50e-05 | 30 | 174 | 4 | 29168693 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GAPVD1 TBC1D15 STRBP CHD4 CUL7 TRIP12 F5 PTPRF MTHFD1 DDX18 SVIL BOP1 HERC2 ARHGEF2 HEATR5B CNOT1 PCNT | 1.67e-05 | 1024 | 174 | 17 | 24711643 |
| Pubmed | 1.97e-05 | 11 | 174 | 3 | 24348274 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FAT4 GAPVD1 FN1 VPS13C IQSEC2 PIWIL2 TRIP12 DSCAML1 ESCO1 DNAH14 MTHFD1 AKAP13 CNOT1 BANK1 | 2.22e-05 | 736 | 174 | 14 | 29676528 |
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 2.22e-05 | 67 | 174 | 5 | 34644545 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 2.22e-05 | 67 | 174 | 5 | 21875946 | |
| Pubmed | Tie2 regulates endocardial sprouting and myocardial trabeculation. | 2.39e-05 | 68 | 174 | 5 | 31112136 | |
| Pubmed | A mouse model for endometrioid ovarian cancer arising from the distal oviduct. | 2.49e-05 | 2 | 174 | 2 | 24474556 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19452449 | ||
| Pubmed | Versican provides the provisional matrix for uterine spiral artery dilation and fetal growth. | 2.49e-05 | 2 | 174 | 2 | 36423736 | |
| Pubmed | Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. | 2.49e-05 | 2 | 174 | 2 | 21982234 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 20056823 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 10053005 | ||
| Pubmed | Mutation analysis of human LEFTY A and LEFTY B genes in children with Ivemark syndrome. | 2.49e-05 | 2 | 174 | 2 | 11100524 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 33500333 | ||
| Pubmed | A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. | 2.49e-05 | 2 | 174 | 2 | 9188753 | |
| Pubmed | Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. | 2.49e-05 | 2 | 174 | 2 | 22976915 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 9211865 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 10545236 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 11809809 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 32400230 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 30852976 | ||
| Pubmed | Mthfd1 is a modifier of chemically induced intestinal carcinogenesis. | 2.49e-05 | 2 | 174 | 2 | 21156972 | |
| Pubmed | Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. | 2.49e-05 | 2 | 174 | 2 | 15604247 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26511139 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25304051 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 31160382 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19793053 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 23201264 | ||
| Pubmed | Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1/2 Signaling Pathways. | 2.49e-05 | 2 | 174 | 2 | 33409963 | |
| Pubmed | Cell adhesion. Fibronectin and integrin knockouts come unstuck. | 2.49e-05 | 2 | 174 | 2 | 7522915 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25007999 | ||
| Pubmed | Molecular analysis of LEFTY-expressing cells in early human embryoid bodies. | 2.49e-05 | 2 | 174 | 2 | 17038673 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 15761860 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 27345391 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 16941501 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 16760206 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 23561487 | ||
| Pubmed | Isolation, characterization, and function of EBAF/LEFTY B: role in infertility. | 2.49e-05 | 2 | 174 | 2 | 21401636 | |
| Pubmed | Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/- mice. | 2.49e-05 | 2 | 174 | 2 | 39055928 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 20172014 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 18027849 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 19531215 | ||
| Pubmed | Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary. | 2.49e-05 | 2 | 174 | 2 | 26446593 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 25143380 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 32745796 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 17489848 | ||
| Pubmed | Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. | 2.49e-05 | 2 | 174 | 2 | 32743790 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 20924072 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 9041176 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 24147624 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 31464639 | ||
| Pubmed | Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. | 2.49e-05 | 2 | 174 | 2 | 22851115 | |
| Pubmed | Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk. | 2.49e-05 | 2 | 174 | 2 | 18612690 | |
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 2.49e-05 | 2 | 174 | 2 | 25355906 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26845241 | ||
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 26654447 | ||
| Pubmed | Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells. | 2.49e-05 | 2 | 174 | 2 | 20171171 | |
| Pubmed | 2.49e-05 | 2 | 174 | 2 | 9496783 | ||
| Interaction | NUP210P1 interactions | 1.35e-06 | 42 | 170 | 6 | int:NUP210P1 | |
| Interaction | ZBBX interactions | 5.73e-06 | 31 | 170 | 5 | int:ZBBX | |
| Interaction | FAHD1 interactions | 1.51e-05 | 171 | 170 | 9 | int:FAHD1 | |
| Interaction | DCANP1 interactions | 1.72e-05 | 19 | 170 | 4 | int:DCANP1 | |
| Interaction | CALM1 interactions | AMFR GAPVD1 STIM2 VPS13C IQSEC2 TOM1 CUL7 LYST ESCO1 MYLK2 DMXL1 VPS13D SVIL PAN2 HERC2 NOS3 PCNT | 2.32e-05 | 626 | 170 | 17 | int:CALM1 |
| Interaction | C2CD4B interactions | 3.35e-05 | 44 | 170 | 5 | int:C2CD4B | |
| Interaction | CARD16 interactions | 4.77e-05 | 9 | 170 | 3 | int:CARD16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 6.74e-07 | 129 | 174 | 7 | chr2q35 | |
| GeneFamily | Cadherin related | 1.44e-04 | 17 | 111 | 3 | 24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.76e-04 | 161 | 111 | 6 | 593 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 6.60e-04 | 28 | 111 | 3 | 745 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.24e-04 | 66 | 111 | 4 | 722 | |
| GeneFamily | Cullins | 1.02e-03 | 8 | 111 | 2 | 1032 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.89e-03 | 40 | 111 | 3 | 592 | |
| GeneFamily | Fibronectin type III domain containing | 3.08e-03 | 160 | 111 | 5 | 555 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.33e-03 | 163 | 111 | 5 | 590 | |
| GeneFamily | Exonucleases | 4.24e-03 | 16 | 111 | 2 | 544 | |
| GeneFamily | Dyneins, axonemal | 4.78e-03 | 17 | 111 | 2 | 536 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.05e-08 | 189 | 174 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | STRBP VPS13C ARHGAP17 LYST DMXL1 PIKFYVE EIF2AK3 BANK1 NOTCH2 | 7.57e-08 | 194 | 174 | 9 | ff661419b697aef51a53fdeac8d37d870d65f491 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-08 | 198 | 174 | 9 | 259fbcc0f2ac281a3e4d693de45b986fe5e24841 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-07 | 185 | 174 | 8 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-07 | 186 | 174 | 8 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.54e-07 | 187 | 174 | 8 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 7.85e-07 | 188 | 174 | 8 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.17e-07 | 189 | 174 | 8 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.17e-07 | 189 | 174 | 8 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.50e-07 | 190 | 174 | 8 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.84e-07 | 191 | 174 | 8 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.84e-07 | 191 | 174 | 8 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.56e-07 | 193 | 174 | 8 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-07 | 193 | 174 | 8 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.94e-07 | 194 | 174 | 8 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-06 | 198 | 174 | 8 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 199 | 174 | 8 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 199 | 174 | 8 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 200 | 174 | 8 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.25e-06 | 200 | 174 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 200 | 174 | 8 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 200 | 174 | 8 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 200 | 174 | 8 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-06 | 200 | 174 | 8 | 7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.34e-06 | 140 | 174 | 7 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-06 | 156 | 174 | 7 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-06 | 156 | 174 | 7 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-endocardial_endothelial_cells|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-06 | 167 | 174 | 7 | a4a795751644b22af616335379e64ae95175180c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.24e-06 | 172 | 174 | 7 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.09e-06 | 176 | 174 | 7 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-06 | 178 | 174 | 7 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-06 | 179 | 174 | 7 | ec7c38464863ac3744a8d4880f49421914892339 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.06e-06 | 180 | 174 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.86e-06 | 183 | 174 | 7 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 8.74e-06 | 186 | 174 | 7 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 189 | 174 | 7 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.70e-06 | 189 | 174 | 7 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.70e-06 | 189 | 174 | 7 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | COVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.00e-05 | 190 | 174 | 7 | 40b5e9e8f8fd8d84cb5b43e67b49267082348e9f | |
| ToppCell | COVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.00e-05 | 190 | 174 | 7 | a37a32dc1b931562a6660074e19d5598efc65284 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.00e-05 | 190 | 174 | 7 | e1b721bb74561fe51c53328a0394c9954e489049 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.00e-05 | 190 | 174 | 7 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 174 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 191 | 174 | 7 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 191 | 174 | 7 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-05 | 191 | 174 | 7 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 174 | 7 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 192 | 174 | 7 | 8df4cfe1461819756138ff1180896238dca2787e | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 193 | 174 | 7 | 724bb613fa434add5b1c5586b629328f819fbdfe | |
| ToppCell | facs-MAT-Fat-24m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 193 | 174 | 7 | 737e540c72a3cfe8dbd4c0f139f7d729a166793a | |
| ToppCell | facs-MAT-Fat-24m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 193 | 174 | 7 | ba9a47e2dc01efa6d2a99b1631d4951fac2648d4 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-05 | 193 | 174 | 7 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.11e-05 | 193 | 174 | 7 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 194 | 174 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-05 | 194 | 174 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 194 | 174 | 7 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 196 | 174 | 7 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 196 | 174 | 7 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.23e-05 | 196 | 174 | 7 | 915e4a7422058be246b54760df31e8a607310625 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-05 | 196 | 174 | 7 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.23e-05 | 196 | 174 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 196 | 174 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 196 | 174 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 196 | 174 | 7 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 196 | 174 | 7 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 197 | 174 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 197 | 174 | 7 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.27e-05 | 197 | 174 | 7 | 87eda06344498dc66cac292cf89746dc90b5cf67 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 197 | 174 | 7 | cd509e49bbdbf991cc5913960ff3ef275ad40628 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 174 | 7 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 197 | 174 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.27e-05 | 197 | 174 | 7 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.27e-05 | 197 | 174 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.27e-05 | 197 | 174 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 198 | 174 | 7 | 31ba87552be97c9b78c9e82f98e96699ccb19824 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 198 | 174 | 7 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | proximal-Endothelial-Artery-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-05 | 198 | 174 | 7 | a56b80bdc824e4cc60366f273fb616cd0efec456 | |
| ToppCell | proximal-3-Endothelial-Artery|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-05 | 198 | 174 | 7 | 946f72b594d22ae7b8e4c22483814c284cb43eea | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.31e-05 | 198 | 174 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | COVID-19-lung-Capillary_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 198 | 174 | 7 | 45419f2804b4be79bae6632e71c54e1af482d115 | |
| ToppCell | proximal-Endothelial-Artery|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-05 | 198 | 174 | 7 | 0e5572298676b6c2a2b1a77967574020b664aebd | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 199 | 174 | 7 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 199 | 174 | 7 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 199 | 174 | 7 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 1.35e-05 | 199 | 174 | 7 | 95403988caef322314f4ed15415ad1a9a987adc1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 199 | 174 | 7 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-Treg|Bac-SEP / Disease, condition lineage and cell class | 1.35e-05 | 199 | 174 | 7 | e0b6136e28b813299b7ffbe37f1cf830e60cd7d8 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 199 | 174 | 7 | ef1a0c278c23614fd6a3218a9733abe6ecd6f686 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.35e-05 | 199 | 174 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 199 | 174 | 7 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-05 | 199 | 174 | 7 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 199 | 174 | 7 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-05 | 199 | 174 | 7 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 199 | 174 | 7 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 199 | 174 | 7 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.40e-05 | 200 | 174 | 7 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 174 | 7 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.40e-05 | 200 | 174 | 7 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.40e-05 | 200 | 174 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 200 | 174 | 7 | ced14d83222dbebca85c40540e76824e683354f3 | |
| Drug | Y-27632 | STARD13 FN1 APC OLR1 MYLK2 PIKFYVE LEFTY2 LEFTY1 MOXD1 MAPK15 RASD1 CDH5 EIF2AK3 NOS3 | 6.59e-06 | 444 | 170 | 14 | CID000005711 |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.09e-05 | 185 | 170 | 9 | 7055_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 1.59e-05 | 194 | 170 | 9 | 3807_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.73e-05 | 196 | 170 | 9 | 3342_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.80e-05 | 197 | 170 | 9 | 3196_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ZNF573 SUPT20H SLC24A3 ACAD10 VPS13D OSBPL2 AKAP13 ARHGEF2 ZC3H7B | 1.87e-05 | 198 | 170 | 9 | 6043_DN |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 1.87e-05 | 198 | 170 | 9 | 4584_UP | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.87e-05 | 198 | 170 | 9 | 3843_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.87e-05 | 198 | 170 | 9 | 4103_UP | |
| Drug | Fluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | ACAD10 PREX2 SIGLEC6 SIPA1L1 PCSK6 ARHGEF2 ZC3H7B SORL1 SOS2 | 2.03e-05 | 200 | 170 | 9 | 6071_DN |
| Disease | Benign neoplasm of stomach | 2.22e-06 | 17 | 167 | 4 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.22e-06 | 17 | 167 | 4 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.22e-06 | 17 | 167 | 4 | C0154060 | |
| Disease | Colorectal Carcinoma | DONSON FN1 POLE FPGS APC KCNB2 F5 DSCAML1 PREX2 AXIN2 ARAP3 DCHS1 PAN2 CDH5 MUTYH SORL1 | 2.66e-06 | 702 | 167 | 16 | C0009402 |
| Disease | Stomach Carcinoma | 5.49e-06 | 21 | 167 | 4 | C0699791 | |
| Disease | Stomach Neoplasms | 8.07e-06 | 297 | 167 | 10 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 8.81e-06 | 300 | 167 | 10 | C0024623 | |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 3.18e-05 | 2 | 167 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 3.18e-05 | 2 | 167 | 2 | cv:C1832390 | |
| Disease | Periventricular gray matter heterotopia | 3.18e-05 | 2 | 167 | 2 | C1849173 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 3.70e-05 | 66 | 167 | 5 | EFO_0003940, EFO_0004611 | |
| Disease | Malignant neoplasm of breast | AMFR FN1 STRBP CYP24A1 ACY1 PGR DAP3 BMPR2 ARAP3 RPRD1A SIPA1L1 DDX18 HERC2 ZNF281 CDH5 NOS3 NOTCH2 SORL1 | 4.08e-05 | 1074 | 167 | 18 | C0006142 |
| Disease | uric acid measurement | FAT4 FAT3 CYP24A1 SLC22A11 ARHGAP17 ACAD10 F5 MLXIPL BMPR2 NFATC2 AKAP13 WDR72 SOS2 | 4.76e-05 | 610 | 167 | 13 | EFO_0004761 |
| Disease | anemia (implicated_via_orthology) | 7.71e-05 | 15 | 167 | 3 | DOID:2355 (implicated_via_orthology) | |
| Disease | Polyposis, Adenomatous Intestinal | 9.45e-05 | 16 | 167 | 3 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 9.45e-05 | 16 | 167 | 3 | C2713443 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Abruptio Placentae | 9.52e-05 | 3 | 167 | 2 | C0000832 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 9.52e-05 | 3 | 167 | 2 | C1842563 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.06e-04 | 189 | 167 | 7 | EFO_0009932 | |
| Disease | Adenomatous Polyposis Coli | 1.14e-04 | 17 | 167 | 3 | C0032580 | |
| Disease | obesity (implicated_via_orthology) | 2.34e-04 | 215 | 167 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | portal hypertension (biomarker_via_orthology) | 2.53e-04 | 22 | 167 | 3 | DOID:10762 (biomarker_via_orthology) | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.79e-04 | 293 | 167 | 8 | C1708349 | |
| Disease | STROKE, ISCHEMIC | 3.15e-04 | 5 | 167 | 2 | 601367 | |
| Disease | Ischemic stroke | 3.15e-04 | 5 | 167 | 2 | cv:C0948008 | |
| Disease | irritable bowel syndrome (implicated_via_orthology) | 3.15e-04 | 5 | 167 | 2 | DOID:9778 (implicated_via_orthology) | |
| Disease | fibroblast growth factor 19 measurement | 3.15e-04 | 5 | 167 | 2 | EFO_0010782 | |
| Disease | inflammatory biomarker measurement | 4.21e-04 | 26 | 167 | 3 | EFO_0004872 | |
| Disease | hepatopulmonary syndrome (biomarker_via_orthology) | 4.71e-04 | 6 | 167 | 2 | DOID:900 (biomarker_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 6.41e-04 | 121 | 167 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | colorectal cancer (implicated_via_orthology) | 6.46e-04 | 30 | 167 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (is_implicated_in) | 6.46e-04 | 30 | 167 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | calcineurin subunit B type 1 measurement | 6.56e-04 | 7 | 167 | 2 | EFO_0020215 | |
| Disease | autoantibody measurement | 6.56e-04 | 7 | 167 | 2 | EFO_0004866 | |
| Disease | putamen volume | 7.12e-04 | 31 | 167 | 3 | EFO_0006932 | |
| Disease | response to aromatase inhibitor | 7.83e-04 | 32 | 167 | 3 | GO_0061477 | |
| Disease | Varicose veins | 8.34e-04 | 193 | 167 | 6 | HP_0002619 | |
| Disease | lung cancer (is_implicated_in) | 8.37e-04 | 74 | 167 | 4 | DOID:1324 (is_implicated_in) | |
| Disease | sialic acid-binding Ig-like lectin 6 measurement | 8.72e-04 | 8 | 167 | 2 | EFO_0008285 | |
| Disease | ovarian cancer (implicated_via_orthology) | 8.72e-04 | 8 | 167 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | polyunsaturated fatty acid measurement | 9.17e-04 | 131 | 167 | 5 | EFO_0010733 | |
| Disease | Disproportionate short stature | 9.71e-04 | 77 | 167 | 4 | C0878659 | |
| Disease | rectum cancer (is_implicated_in) | 1.12e-03 | 9 | 167 | 2 | DOID:1993 (is_implicated_in) | |
| Disease | Situs ambiguous | 1.12e-03 | 9 | 167 | 2 | C1167664 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.12e-03 | 80 | 167 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 1.39e-03 | 10 | 167 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | cancer antigen 125 measurement | 1.39e-03 | 10 | 167 | 2 | EFO_0010603 | |
| Disease | Pulmonary Hypertension | 1.51e-03 | 40 | 167 | 3 | C0020542 | |
| Disease | Posterior Choroidal Artery Infarction | 1.69e-03 | 11 | 167 | 2 | C0887799 | |
| Disease | Gastric cancer | 1.69e-03 | 11 | 167 | 2 | cv:C0024623 | |
| Disease | Cerebral Infarction, Left Hemisphere | 1.69e-03 | 11 | 167 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 1.69e-03 | 11 | 167 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 1.69e-03 | 11 | 167 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 1.69e-03 | 11 | 167 | 2 | C0751014 | |
| Disease | Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement | 1.69e-03 | 11 | 167 | 2 | EFO_0009923 | |
| Disease | Neoplasm of stomach | 1.69e-03 | 11 | 167 | 2 | cv:C0038356 | |
| Disease | Cerebral Infarction | 1.69e-03 | 11 | 167 | 2 | C0007785 | |
| Disease | vascular endothelial growth factor D measurement | 1.69e-03 | 11 | 167 | 2 | EFO_0010575 | |
| Disease | endometrial carcinoma, endometriosis | 1.69e-03 | 11 | 167 | 2 | EFO_0001065, EFO_1001512 | |
| Disease | GASTRIC CANCER | 1.69e-03 | 11 | 167 | 2 | 613659 | |
| Disease | Secondary Biliary Cholangitis | 1.74e-03 | 42 | 167 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 1.74e-03 | 42 | 167 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 1.74e-03 | 42 | 167 | 3 | C4551595 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.89e-03 | 307 | 167 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | IGF-1 measurement | 1.93e-03 | 488 | 167 | 9 | EFO_0004627 | |
| Disease | Paroxysmal atrial fibrillation | 1.99e-03 | 156 | 167 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 1.99e-03 | 156 | 167 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.99e-03 | 156 | 167 | 5 | C2585653 | |
| Disease | endometrial carcinoma (is_implicated_in) | 2.02e-03 | 12 | 167 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | pulmonary embolism (biomarker_via_orthology) | 2.02e-03 | 12 | 167 | 2 | DOID:9477 (biomarker_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 2.19e-03 | 96 | 167 | 4 | C1319315 | |
| Disease | Atrial Fibrillation | 2.22e-03 | 160 | 167 | 5 | C0004238 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 2.38e-03 | 13 | 167 | 2 | EFO_0802114 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.38e-03 | 13 | 167 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Primary biliary cirrhosis | 2.40e-03 | 47 | 167 | 3 | C0008312 | |
| Disease | testosterone measurement | STARD13 CYP7A1 CYP24A1 IQSEC2 SLC22A11 SLC24A3 NUF2 KIAA0753 MLXIPL PTPRF MTHFD1 KNDC1 MED23 BANK1 WDR72 SOS2 | 2.47e-03 | 1275 | 167 | 16 | EFO_0004908 |
| Disease | non-high density lipoprotein cholesterol measurement | AMBN FN1 CYP7A1 BBS1 MLXIPL BMPR2 OIT3 DDX18 FUT2 DNAH11 WDR72 | 2.56e-03 | 713 | 167 | 11 | EFO_0005689 |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.71e-03 | 49 | 167 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Weight Gain | 2.73e-03 | 102 | 167 | 4 | C0043094 | |
| Disease | multiple myeloma, monoclonal gammopathy | 2.77e-03 | 14 | 167 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 3.19e-03 | 15 | 167 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | Situs ambiguus | 3.19e-03 | 15 | 167 | 2 | C0266642 | |
| Disease | Myocardial Ischemia | 3.34e-03 | 176 | 167 | 5 | C0151744 | |
| Disease | gallstones | 3.36e-03 | 108 | 167 | 4 | EFO_0004210 | |
| Disease | smoking behavior | 3.39e-03 | 341 | 167 | 7 | EFO_0004318 | |
| Disease | IGFBP-3 measurement | 3.57e-03 | 54 | 167 | 3 | EFO_0004626 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 3.57e-03 | 54 | 167 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | Ciliopathies | 3.59e-03 | 110 | 167 | 4 | C4277690 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 3.63e-03 | 16 | 167 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | C-reactive protein measurement | ARMC7 ZNF573 VPS13C CCDC168 HID1 KCNB2 TRIP12 IL22RA1 MLXIPL BMPR2 PTPRF FUT2 BANK1 DNAH11 WDR72 | 3.65e-03 | 1206 | 167 | 15 | EFO_0004458 |
| Disease | Breast Carcinoma | 3.68e-03 | 538 | 167 | 9 | C0678222 | |
| Disease | very low density lipoprotein cholesterol measurement | 3.74e-03 | 260 | 167 | 6 | EFO_0008317 | |
| Disease | Lipidemias | 4.10e-03 | 17 | 167 | 2 | C1706412 | |
| Disease | Amelogenesis imperfecta | 4.10e-03 | 17 | 167 | 2 | cv:C0002452 | |
| Disease | Hyperlipidemia | 4.10e-03 | 17 | 167 | 2 | C0020473 | |
| Disease | antihyperlipidemic drug use measurement | 4.20e-03 | 115 | 167 | 4 | EFO_0803367 | |
| Disease | Carcinoma, Granular Cell | 4.33e-03 | 116 | 167 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.33e-03 | 116 | 167 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.33e-03 | 116 | 167 | 4 | C0205642 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQLERPHFTLPGTMV | 521 | Q8NDB2 | |
| FFSGDVMIHPVTNRP | 226 | Q14137 | |
| MESSELIPRPGHQFA | 116 | Q68DN1 | |
| LLQHSPSPIGSTRML | 926 | Q86US8 | |
| GHEVTLSNLNLSMPP | 86 | Q9UBC2 | |
| PPENTFLRLTAMATH | 556 | P16452 | |
| PVRFLFVMLGPSHTS | 551 | P48751 | |
| MSHLPAVSPVFFQLP | 1 | Q5TEZ4 | |
| IQRFSDLLPMGVPHI | 356 | P20813 | |
| TPALRPTTGTVHIMD | 186 | Q8WWN8 | |
| GFPTVSVMLPLHSEQ | 2481 | P13611 | |
| VLTPMPAYARHTGQV | 971 | Q9NZJ5 | |
| TIFQIARLISHGPMP | 216 | Q9NP70 | |
| SPPHSPRDFTRMQDI | 956 | Q92974 | |
| HNPSLRAPMFLLIGS | 71 | P47775 | |
| IQRHSPLGFARQSPM | 4651 | Q6V0I7 | |
| LMTISHPGLDNSRPF | 1691 | Q12802 | |
| PMVGSFTINPRLQRH | 2626 | Q96DT5 | |
| HRQQSVLLVPMDTPG | 851 | Q6JQN1 | |
| RTTPRAHLFTQDPAM | 671 | Q9Y2T1 | |
| LAQSHPEMGLVTTPV | 316 | Q5T2E6 | |
| QAMPHPQLFSGESVV | 1686 | Q9NYQ6 | |
| HFLPVVISDNGMPSR | 551 | P33151 | |
| TGMVYQTVLLPHRPS | 2261 | Q9Y485 | |
| PFLRENDLSIMHSPS | 46 | O14525 | |
| ILDTSGNHPFPAMRR | 76 | Q9Y272 | |
| GNHPFPAMRRLSILT | 81 | Q9Y272 | |
| PQHMVGATPFAVARL | 61 | Q96AZ6 | |
| SIVIQGFPHPEMTTS | 7651 | Q8WXI7 | |
| TPSHELIQAVGPLRM | 116 | Q13469 | |
| EMQPLAHGASTVLPS | 2206 | Q04721 | |
| ADIFHVNPVGPLLMT | 321 | Q504Q3 | |
| FTVDPTTGHVRLMRP | 941 | Q96JQ0 | |
| RMPAYIATQGPLSHT | 776 | Q16849 | |
| THLLVFGMEQRLPPN | 96 | O75610 | |
| PGTTEHLRFTRPLTM | 301 | Q96EK9 | |
| ISPSAALRHPFVSMQ | 336 | Q8NE63 | |
| HFELPGPRMVVTNLL | 376 | Q0VAK6 | |
| MSSFGPDSLLLPHRV | 4451 | O95714 | |
| NPQIFTAHPDTMLGR | 131 | Q7Z5Y7 | |
| MLRGRPLFPGTSTLH | 211 | Q8TD08 | |
| SSIRHVPANVGPLMR | 4431 | Q8NDA2 | |
| IEGSVISSPRPHQRM | 1166 | Q5JU85 | |
| LPNFGSHVLTPAEME | 871 | Q14C86 | |
| SSRGPHTFLRMDPQV | 121 | P29122 | |
| PLEIMSRNHGIFPFT | 376 | Q8WWZ8 | |
| PHLMEGFLPFSNLVT | 76 | Q9BZD4 | |
| PFPHRMVELRTGNVS | 266 | Q9H1R3 | |
| SEHPMSFEGIQLPQV | 231 | Q14999 | |
| LREPVIQHGPFVMNT | 246 | O00625 | |
| IITHFSMQGSPPLFL | 776 | Q9ULK4 | |
| HSVMFNPVEPRLLAT | 191 | Q96JK2 | |
| SLENIARMTHALFPP | 221 | Q8N8W4 | |
| GNRLTDFPTVLLHMP | 176 | Q5BKY1 | |
| LSAITTLMHLSPPGR | 116 | Q9H6L4 | |
| TELSEMFPVLPGSHL | 2081 | Q07864 | |
| MAVQAALLSTHPFVP | 1 | A6NEQ2 | |
| TLRPASPLMHIQGFL | 556 | Q96FC9 | |
| VATPGRLLDHMQNTP | 306 | Q9NVP1 | |
| RHIIYIDQPTLGMPS | 246 | Q495T6 | |
| HMGIRLSQSPLDPRS | 391 | Q8WWR8 | |
| PSFHAIMGPLQALLT | 706 | P78316 | |
| SPLMPHLFRVRGAVS | 221 | P78380 | |
| VSDHPPEQRGMFTIS | 161 | O95613 | |
| PEQRGMFTISDHQPE | 166 | O95613 | |
| SEAGLRIMITSHFPP | 326 | Q9HC58 | |
| PISGSLTPVFHQEMV | 451 | P29474 | |
| TGFSSIFPGIRPHLM | 126 | Q3SYC2 | |
| PGRSPLATTVMDFIH | 291 | P06401 | |
| MGSRTPESPLHAVQL | 1 | P08648 | |
| MGPEHSSARPERFLQ | 786 | Q02218 | |
| PTLMQNPSFHSLIEG | 881 | Q9Y2I7 | |
| MFAPRHVNLSSLVPS | 1056 | Q9P2D3 | |
| SHLSLGEIPAMAQPF | 301 | P46976 | |
| ASHLQMKFPTDLPGT | 626 | Q92953 | |
| NTTRIHLLPSMNPDG | 281 | Q66K79 | |
| EPVEMLHSGTLVPSR | 491 | Q07973 | |
| SRHGLIPLVNSMDVP | 216 | Q9H0R6 | |
| HPTLIQSTGPLIDMS | 1706 | Q8TD84 | |
| MIFEEHGFRRTTPPT | 2141 | P02751 | |
| RPAFIPAQMHSTLAP | 91 | Q10981 | |
| PAQMHSTLAPIFRIT | 96 | Q10981 | |
| QEMTTFHPESPRILT | 4261 | Q8TDW7 | |
| MEHSLKQFSGPDPLS | 686 | Q13873 | |
| EDRFHGVRLQTSPPM | 351 | Q9Y2G2 | |
| HEMRVVSPVFLQLPS | 181 | F5H4A9 | |
| NLHIFVIMSPEGPSF | 2136 | Q0VDD8 | |
| THLLVFGMEQRLPPN | 96 | O00292 | |
| GTVLHFLVRMPPFTK | 3241 | Q99698 | |
| HEQRSPPGSSRELVM | 391 | Q9P2E8 | |
| DQFSLEITGPIMPHS | 466 | Q9NYP3 | |
| LPLLSSVQIEGHPMS | 496 | Q8N6P7 | |
| LPGTMRPLHVRTTSD | 331 | P05111 | |
| LAPVFQPTSHMRLGL | 341 | Q05932 | |
| MPPLAHIFRGTFVHS | 6 | Q9Y2T3 | |
| FRAQPTLPSAHLLAM | 1636 | Q76NI1 | |
| TLFRHSGIAPRTEPM | 896 | Q8IWT3 | |
| FPALVAGLPIHMFRT | 216 | P22680 | |
| GLLRTSFSPPALEMH | 416 | Q5FWF5 | |
| SFMPHLEIQESLPSR | 4721 | Q8NDH2 | |
| MSNSHPLRPFTAVGE | 1 | Q96Q07 | |
| TFLMEQHEPRTPALA | 91 | Q8NFJ9 | |
| PSHPSMALNTRFAEV | 1811 | Q14839 | |
| FPTPVRMTADGILHT | 456 | Q9NSA0 | |
| FPRPATSHSLLGMEV | 711 | Q96RY7 | |
| SHPENLLPSIFIMGS | 1746 | Q8TDX9 | |
| PNLMQTLEGTPVFVH | 621 | P11586 | |
| FDLSMPHVQDPSLVR | 1116 | P10586 | |
| TPHAIIFLPNTDGME | 1211 | Q8N4C8 | |
| HGLPPRFVMQVKTFS | 81 | P51398 | |
| RQLLTMVSHGPVAPR | 286 | Q8NBS3 | |
| LNSMAPHPSRDFVVL | 1001 | Q9Y3M8 | |
| LAFEHVMTRGVRPPA | 1831 | Q92673 | |
| PGQFETFDLMTLHPI | 766 | Q07890 | |
| IHAGLEPLTFTNMFP | 2106 | O95425 | |
| LGQMPISPDLSHTTL | 1226 | P12259 | |
| LGQMPISPDLSHTTL | 1316 | P12259 | |
| SPNTLILSHFVGRPM | 551 | Q7Z494 | |
| NSRVSEPHRSIFPEM | 841 | Q68EM7 | |
| PIVLLSGSMEPAFHR | 36 | P0C7V7 | |
| EVTRDPSILTIPMHF | 591 | Q8TC59 | |
| FIGMLPSPNQVEHLS | 236 | A6NCM1 | |
| FMSPGPLVRVTFHAL | 931 | Q7RTY7 | |
| RVPMDIPVFTGTHAD | 446 | Q8IV36 | |
| VYLRVASGPMPVHTT | 141 | D6RGX4 | |
| QFRTTPMDSTGVPHI | 91 | Q5JRX3 | |
| HTSVILNRMAPVLPS | 71 | Q9NZE8 | |
| PSGRLMRQDPVVHLS | 1256 | O43166 | |
| VMALTHRPNISIPGT | 141 | O43699 | |
| TLRGDAHSPPLMTFQ | 181 | Q3SXP7 | |
| LLSQSGPVHAPVFTM | 406 | Q96SI9 | |
| GHMPRTAETLQQLLP | 196 | Q9UIF7 | |
| ASPSLVSQHLIRPLM | 126 | Q9H9Q4 | |
| TSRHISVGPFPILSM | 121 | P40879 | |
| MFVTQFTDRGEHPLP | 316 | Q2KHM9 | |
| HMEPPLGGLRFFSTQ | 436 | Q8NA69 | |
| PATGVPITHQRFDQM | 736 | Q9NP71 | |
| GTMIPSEAPLLHRQV | 106 | Q96A35 | |
| MLSLIPQPQDHGTSL | 326 | Q96PQ1 | |
| GIQKHRTSLPAPMFS | 56 | Q9H1P3 | |
| PLSTLPMFNVHTGER | 356 | Q16586 | |
| LSMPPIINGDHSRIT | 231 | Q9NSD9 | |
| PRAIQTPGNSSLMLH | 131 | Q6PIS1 | |
| PTTPMSSHGRVLSLL | 176 | Q9UKV5 | |
| TPSNEHFGIVPLEAM | 321 | Q9H553 | |
| GFSPMNRTPVLLHDH | 361 | Q03154 | |
| NIMSPGSSLPSLHVR | 741 | P25054 | |
| HTFPEVQRMPSQISL | 191 | Q7Z7G1 | |
| ELISTLMPIFLGNHP | 501 | A5YKK6 | |
| APKSQFGRIIHTPFM | 371 | P48995 | |
| ESMHSIPLTNLAIPG | 21 | Q63HM9 | |
| VGVQFHPEFSSRPMK | 521 | Q9NRF8 | |
| PLPEHRSNTMFISET | 376 | Q96HI0 | |
| PTHSAEMSLFLQGPE | 6 | Q5VV52 | |
| MFPVLEPHQVGLIRS | 1 | Q86YE8 | |
| LEGHAMPIRSLTFSP | 186 | Q9GZS3 | |
| SSRVFMPPHDLLARV | 76 | Q8N9B8 | |
| SLFHTIPPGMPEFQS | 346 | Q6UVY6 | |
| LPDLSRLPNVTGSHM | 286 | Q96P16 | |
| TTLPRIAVHEPSFMI | 166 | Q9P246 | |
| RQMLPPVEGVHLLSS | 566 | O95935 | |
| LDMLSPIHTPQRTVF | 156 | O60784 | |
| SPGYQSRHILLRPTM | 156 | Q8NEM7 | |
| IPLFSEPTKTTMQGH | 41 | Q9H5I5 | |
| GLLPATVQPFHLRGM | 71 | Q9Y5U2 | |
| PPHSITAIMITDDQR | 16 | Q3MJ13 | |
| RMSHLPPDFEGRQTV | 166 | Q9UK41 | |
| TAFRNHPQLSPMISG | 256 | Q9UJ04 | |
| VMFNHRLPPVTSFTR | 51 | Q9Y2X9 | |
| ILDTSGNHPFPAMRR | 71 | Q96D21 | |
| GNHPFPAMRRLSILT | 76 | Q96D21 | |
| VPQDTAPLMFSRRHS | 616 | A0A0J9YWL9 | |
| VVPQGTAPLMFSRRH | 676 | A0A0J9YWL9 | |
| FIPEPQMAIHISSGN | 2371 | Q709C8 | |
| SHGLPPRYIMQATDV | 1551 | Q70Z35 | |
| VGSLVSPPISLHIFM | 311 | Q9BZZ2 | |
| PSTHQRPPSEMADFL | 266 | Q8TC07 | |
| HPREEMNVPSLRSGS | 351 | Q3C1V9 | |
| TPEDMPTFSIQHQRI | 41 | Q14585 | |
| FGPLGPRMSQLFHRT | 416 | Q14669 | |
| HATMDPQRLGVLITP | 316 | P78423 | |
| PRTHGPSTFDLQMKF | 681 | Q9UGR2 | |
| IMPGDSFAVPLHLTS | 3081 | Q5THJ4 | |
| SEFHLVPSRSMNGQP | 206 | Q96NY8 |